SCHEMBL14060283

SCHEMBL14060283

NC(=O)c1nnc2cc(-c3cccc4c3NC(=O)C4)ccc2c1NCCC1CC1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14059473 0.87 LRRK2 (0.69) LRRK2
SCHEMBL14059777 0.84 LRRK2 (0.67) LRRK2
SCHEMBL14059522 0.84 LRRK2 (0.67) LRRK2
SCHEMBL14059183 0.84 LRRK2 (0.51) LRRK2
SCHEMBL14061551 0.82 LRRK2 (1.00) LRRK2
SCHEMBL14061554 0.82 LRRK2 (1.00) LRRK2
SCHEMBL14059953 0.81 LRRK2 (0.62) LRRK2
SCHEMBL14059649 0.81 LRRK2 (0.65) LRRK2
SCHEMBL14059393 0.79 LRRK2 (0.67) LRRK2
SCHEMBL14059208 0.78 LRRK2 (0.61) LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2726465-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY Elan Pharmaceuticals Inc. (US) 2014-05-07 — — EP claimed
WO-2012162254-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY ELAN PHARMACEUTICALS, INC. (US) 2012-11-29 — — WO claimed
EP-2726465-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY Elan Pharmaceuticals Inc. (US) 2014-05-07 — — EP disclosed
WO-2012162254-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY ELAN PHARMACEUTICALS, INC. (US) 2012-11-29 — — WO disclosed
Send feedback